MATSUO Kazuhiko

マツオカズヒコ | MATSUO Kazuhiko

Affiliation and department：
Homepage URL (1)： http://kaken.nii.ac.jp/d/r/70615921.ja.html

Research field (2)： Infectious disease , Clinical pharmacy

Research keywords (6)：免疫記憶 , ワクチンアジュバント , ケモカイン , 自己溶解型マイクロニードル , 経皮ワクチン , アルツハイマー病

Research theme for competitive and other funds (8)：

2023 - 2026 ケモカインCCL28の好酸球を介したメラノーマ腫瘍免疫における役割
2020 - 2023 乾癬におけるケモカイン受容体CCR4を介したTh17細胞増殖の病理的役割の解明
2020 - 2023 Memory CTL-inducing vaccine sistem targeting P2 recepors
2017 - 2020 Identification of a novel receptor for ELC/CCL19 and its role in psoriasis
2015 - 2017 Establishment of skin inflammation drug to accumulate high-functional regulatory T cells by single-cell gene expression analysis

Show all

Papers (60)：

Yuta Hara, Tatsuma Honzawa, Moeka Kitagawa, Ritsuki Sano, Kazuhiko Matsuo, Takashi Nakayama. Aggravation of lipopolysaccharide-induced depressive-like behavior in CCR4-deficient mice. Journal of Pharmacological Sciences. 2023. 153. 3. 89-93
Masako Sato, Kazuhiko Matsuo, Yoko Susami, Ayaka Yamashita, Haruko Hayasaka, Yuta Hara, Keiji Nishiwaki, Naoki Oiso, Akira Kawada, Atsushi Otsuka, et al. A CCR4 antagonist attenuates atopic dermatitis-like skin inflammation by inhibiting the recruitment and expansion of Th2 cells and Th17 cells. International Immunology. 2023. 35. 9. 437-446
Tomonori Higuchi, Yumiko Hashida, Kazuhiko Matsuo, Kosuke Kitahata, Takako Ujihara, Ichiro Murakami, Takashi Nakayama, Masanori Daibata. EBV-positive pyothorax-associated lymphoma expresses CXCL9 and CXCL10 chemokines that attract cytotoxic lymphocytes via CXCR3. Cancer science. 2023. 114. 6. 2622-2633
Elo Madissoon, Amanda J Oliver, Vitalii Kleshchevnikov, Anna Wilbrey-Clark, Krzysztof Polanski, Nathan Richoz, Ana Ribeiro Orsi, Lira Mamanova, Liam Bolt, Rasa Elmentaite, et al. A spatially resolved atlas of the human lung characterizes a gland-associated immune niche. Nature genetics. 2023. 55. 1. 66-77
Tatsuma Honzawa, Kazuhiko Matsuo, Shunya Hosokawa, Mayu Kamimura, Yuichiro Kaibori, Yuta Hara, Daisuke Nagakubo, Naoki Oiso, Akira Kawada, Atsushi Otsuka, et al. CCR4 plays a pivotal role in Th17 cell recruitment and expansion in a mouse model of rheumatoid arthritis. International immunology. 2022. 34. 12. 635-642

ｍore...

MISC (65)：

山下絢香, 松尾一彦, 須佐美陽子, 早坂晴子, 原雄大, 中山隆志. CCR4 antagonist ameliorated atopi dermatitis by inhibiting infiltration and expansion of CCR4-expressing Th2 cells and Th17 cells in mice. 日本薬学会年会要旨集(Web). 2023. 143rd
西田晃尚, 山本真也, 松尾一彦, 早坂晴子, 海堀祐一郎, 長久保大輔, 原雄大, 義江修, 義江修, 中山隆志. Chemokine CCL28-mediated antitumor immunity against a murine melanoma. 日本薬学会年会要旨集(Web). 2023. 143rd
坂本裕介, 萬瀬貴昭, 楡光世, 綿原光司, 原雄大, 松尾一彦, 中山隆志, 森川敏生, 森川敏生. Neolignan from the fruit of Alpinia galanga as antagonists of CC chemokine receptor-3. 日本農芸化学会大会講演要旨集(Web). 2022. 2022
森川敏生, 森川敏生, 萬瀬貴昭, 坂本祐介, 綿原光司, 原雄大, 松尾一彦, 中山隆志. 紅豆こう(Alpinia galanga,果実)ケモカイン受容体CCR3選択的アンタゴニスト作用を指標とした抗アレルギー作用成分の探索. 日本生薬学会年会講演要旨集. 2021. 67th
松尾一彦, 中山隆志. 細胞遊走. ファルマシア. 2020. 56. 4. 335_2-335_2

ｍore...

Books (6)：

応用が拡がるDDS - 人体環境から農業・家電まで -
エヌ・ティー・エス 2013
Bio-Nanotechnology: A Revolution in Food, Biomedical and Health Sciences
Wiley-Blackwell 2013
ドラッグデリバリーシステムの新展開II - 核酸医薬・抗体医薬・ワクチン医療を支えるDDS技術
シーエムシー出版 2012
次世代バイオ医薬品の製剤設計と開発戦略
シーエムシー出版 2011
次世代経皮吸収型製剤の開発と応用
シーエムシー出版 2011

ｍore...

Professional career (1)：

PhD (Osaka University)

Work history (4)：

2023/04 - 現在 Kindai University Faculty of Pharmacy Department of Pharmacy
2017/04 - 2023/03 Kindai University Faculty of Pharmacy, Department of Pharmacy
2012/04 - 2017/03 Kindai University Faculty of Pharmacy, Department of Pharmacy
2011/04 - 2012/03 Osaka University

Awards (2)：

2011 - 日本薬学会近畿支部日本薬学会近畿支部奨励賞(医療薬) 感染症予防対策に資する経皮ワクチン製剤 (貼るワクチン) の開発
2010 - ファーマバイオフォーラム2010 優秀発表賞

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page